Scio Diamond Hits Milestone with Mosaic Diamond Growth Production

Scio Diamond Technology Corporation (SCIO)

Scio Diamond Technology Corp. (OTCBB: SCIO), a leading producer of cultured diamonds through a patented chemical vapor process, reported this morning that it is now in production with its Mosaic Diamond growth process.  Hitting this milestone allows the company to grow large plates of single crystal diamonds that are unparalleled in size anywhere in the world, according to the company.

Scio’s chief executive Joe Lancia said that with the company’s success in growing multiple plates of diamond in the size of 4.5mm x 18mm x 3.2mm deep, both mass production and fabrication are greatly simplified.

“This is one of our most significant achievements yet,” said Lancia.

The company decided to forgo a different technology of theirs to move right into employing their cutting-edge Mosaic technology.  ”We decided to skip over our S3724 technology and go directly to our one-of-a-kind Mosaic technology,” said Mike McMahon, Scio’s Chief Operating Officer.  “We had the large Scio-produced mosaic seed stock in inventory and the confidence in our operational personnel to grow diamond with that stock,” McMahon added.

After moving its production operations from the northeast U.S. to Greenville, South Carolina late in 2011, the company has wasted no time moving forward.  Upon installation, reactors went into production of CVD single crystal diamonds early in May.  Scio plans to produce over 150,000 gross carats annually from less than 15 reactors.

According to the company, sales agreements have been consummated and shipment has begun as part of a multi-year/multi-million dollar contract with an international supplier of precision diamond cutting tools and products.

The diamonds have the identical chemical, physical and optical properties as diamonds found in the earth, and the company’s highly controlled manufacturing process enables it to produce very high-quality, high-purity, high volume, single-crystal colorless, near colorless and fancy colored diamonds.  Although there is always a market for the diamonds in the jewelry space, the clear opportunity that the company intends to capitalize on is outside that realm with diamonds in high demand in the technology industry.

Shares of SCIO have been on the upswing since the end of June when shares dipped to $2.25 each.  A climb to exceed $3 each followed where shares have been channeling between $2.80 and $3.10 for the last month on increased volume.

Scio Diamond Technology Corp. (SCIO) Stock Quote and News:

Disclaimer: Neither nor its officers, directors, partners, employees or anyone involved in the publication of the website or newsletters (“us” or “we”) is a registered investment adviser or licensed broker-dealer in any jurisdiction whatsoever. Further, we are not qualified to provide any investment advice and we make no recommendation to purchase or sell any securities. The prior article is published as information only for our readers. is a third party publisher of news and research. Our site does not make recommendations, but offers information portals to research news, articles, stock lists and recent research. Nothing on our site should be construed as an offer or solicitation to buy or sell products or securities. This site is sometimes compensated by featured companies, news submissions and online advertising. Viper Enterprises, LLC (parent company of OTC Showcase) has received no compensation for this article from and owns no shares of the aforementioned company(ies). Please read and fully understand our entire disclaimer at


Add your comment

Commenting is allowed only for registered users.

Other articlesgo to homepage

Stocks Struggle for a Reason to Move on Tuesday

Stocks Struggle for a Reason to Move on Tuesday(0)

American stocks were mixed with the Dow edging lower and the S&P 500 and Nasdaq squeaking ahead on Tuesday as a lack of conviction kept investors on the sidelines. Sentiment is torn ahead of quarterly reports starting to flow in and the euro zone’s financial turmoil as Spain is in focus in need of a

Markets End Mixed on First Day of Fourth Quarter

Markets End Mixed on First Day of Fourth Quarter(0)

A rally on Wall Street lost steam Monday afternoon following comments from Federal Reserve chairman Ben Bernanke. Stocks had started the day strong as data from the Institute for Supply Management showed that its manufacturing index climbed into expansion territory for the first time after three straight months of contraction. Traders also found solace in

Cardium Increases Product Portfolio with Acquisition of To Go Brands

Cardium Increases Product Portfolio with Acquisition of To Go Brands(0)

Cardium Therapeutics (NYSE MKT: CXM) today announced that its MedPodium® operating unit has acquired the assets, business and product portfolio of privately-held To Go Brands® to support the expansion of Cardium’s health sciences nutraceutical brand platform. To Go Brands have introduced products in a number of food, drug and mass channel retailers, and the company

Touchdown!  NFL Refs Return to Field Thursday

Touchdown! NFL Refs Return to Field Thursday(0)

Not to knock the referees that filled-in during the lock-out of NFL officials as they did a pedestrian job, but the atrocious call on Monday Night Football between the Seahawks and the Packers was just about enough of the replacements.  Today, the National Football League said that a new eight-year deal with the NFL Referees

US Markets Drift Lower Ignoring Decent Economic Data

US Markets Drift Lower Ignoring Decent Economic Data(0)

U.S. stocks drifted lower Tuesday afternoon as worries about global economic growth overshadowed positive reports on the U.S. housing market and consumer confidence. The Dow Jones Industrial average was sharply lower, by 101.37 points, to finish at 13,457.50 The S&P 500 index subtracted 15.30 points, to 1,441.59, and the Nasdaq Composite Index got bruised 43.06

read more

Stay Informed

Receive the OTCS Newsletter *


* required

Dana-Farber to Host Cellceutix Trials

Cellceutix Corporation (CTIX)
Cellceutix Corporation has filed its Investigational New Drug application with the FDA. Dana-Farber and Beth Israel Deaconess Medical Center will be hosting the clinical trials for Kevetrin, Cellceutix's novel cancer drug. Read more news and get a stock quote.

Diabetes Rate Growing Exponentially

According to the International Diabetes Federation, more than 500 million people will be diagnosed with diabetes in the next two decades, a more than 50 percent increase from today. Technologies are available presently to help manage the frequency, complications and costs associated with diabetes. Read the complete article to learn more.

Contacts and information

Have an opinion or news that you want to share?

Social networks

Most popular categories

© 2011 Viper Enterprises, LLC. All rights reserved.